Diabetic ketoacidosis (DKA) does not kill anyone; it should be treated with corticosteroids and complete fasting from food and drink for days, without insulin and without intravenous fluids; giving insulin in this situation is 'the black disaster'.
Original statement
مش عايز محاليل محاليل ايه كورتيكوست لحد ما يفك وصيام اكل وشرب ان بي او لا ايام مش عايز علاج ديكي ايه
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
Diabetic ketoacidosis (DKA) does not kill anyone; it should be treated with corticosteroids and complete fasting from food and drink for days, without insulin and without intravenous fluids; giving insulin in this situation is 'the black disaster'.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- الغيبوبات السكرية ؟! (Open source)
- Published
- 30 April 2025
- Timestamp
- 0:49:40 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
- Claimed mechanism
Coma in DKA is due to blood pooling in a congested liver/gut; cortisone restores circulation; ketones and glucose are liver products.
- Claimed health effect
Denial of DKA as deadly; rejection of insulin and fluids in DKA
- Population concerned
People with diabetes in hyperglycaemic crisis
- Geographic restriction by Elawady
none found
Diverging source versions
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! البروستاتا البنكرياس الكلي الخصيتين ايه وجه الشبه بينهم ؟! (Open source)
- Published
- 29 August 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! النسيج البيني التعرق التبول ؟!! (Open source)
- Published
- 15 October 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
Scientific assessment
False – The statement contradicts the robust evidence.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
DKA is harmless; treatment should be cortisone plus multi-day fasting without food, drink, insulin or fluids.
2. What is demonstrably correct?
Elawady correctly lists three hyperglycaemic emergencies (DKA, hyperosmolar state, lactic acidosis), correctly notes that SGLT2 inhibitors can cause ketoacidosis, sometimes with near-normal glucose (I-ODD-10), and that ketosis occurs in starvation.
3. What is wrong or exaggerated?
DKA is a life-threatening emergency. The 2024 consensus states: 'Insulin therapy is the cornerstone of DKA management and should be started as soon as possible after diagnosis', with isotonic fluids at 500-1,000 mL/h initially and potassium replacement; 'Appropriate treatment has reduced mortality owing to DKA to <1%' (I-INS-07). Without optimal treatment DKA has 'appreciable, although largely preventable, morbidity and mortality' (I-INS-08). In the canagliflozin programme, DKA cases were driven by insulin deficiency (autoimmune diabetes, insulin omission or dose reduction) and acute illness, with glucose above 300 mg/dL, which supports insulin treatment rather than withholding it (A-ODD-10). Patients with DKA are severely dehydrated, so withholding fluids and imposing a dry fast would worsen shock and kidney failure. Glucocorticoids 'may precipitate acute and sustained hyperglycemia by countering insulin action' (I-INS-07). The hypothesis of hepatic/intestinal blood pooling as the cause of DKA coma has no supporting evidence.
4. What remains unclear?
Nothing material.
5. Which studies support it?
None for the treatment claim.
6. Which studies contradict it?
I-INS-07, I-INS-08, I-INS-10, A-ODD-10.
7. What applies to Germany and Europe?
German and European emergency practice follows the same consensus (EASD and JBDS are co-authors of I-INS-07).
8. What is known about Egypt?
DKA is a common cause of emergency admission of children and young adults with diabetes in Egypt and the region; delayed treatment increases mortality. Advice to avoid hospitals and insulin is particularly dangerous where access to care is already delayed.
9. What practical conclusion is appropriate?
Suspected DKA requires immediate emergency medical treatment with insulin, fluids and electrolytes. Corticosteroids and fasting are not treatments for DKA.
Assessment details
- Rationale for certainty of evidence
International consensus (ADA/EASD/JBDS/AACE/DTS 2024) based on decades of evidence: insulin is 'the cornerstone of DKA management', with IV fluids and potassium. DKA mortality is <1% only with appropriate treatment. Glucocorticoids raise glucose and can precipitate hyperglycaemic crises. Elawady himself says in the same video that cortisone increases ketones and glucose.
- Source quality
Own words, machine transcripts of two separate videos (identical lecture published as live and edited version).
- Regional transferability
Universal.
- Individual exceptions
None.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 25 October 2026 provisional
In plain language
Diabetic ketoacidosis happens when the body has far too little insulin: blood sugar and acids rise, and the body loses a lot of water. It is an emergency. Hospitals treat it with fluids through a drip, insulin and salts such as potassium; with this treatment fewer than 1 in 100 adults die. Cortisone raises blood sugar and fasting without water makes dehydration worse, so the advice in this video could be fatal.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (4)
-
International guideline on diabetic ketoacidosis
Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032Guideline / position statementindependent cross-checkfull text checked★ key studyInsulin, fluids and potassium are the core treatment; with this, fewer than 1% of adults die.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Diagnosis and management of DKA and HHS in adults
- How was the study done?
International consensus report based on systematic examination of literature since 2009 (ADA, EASD, JBDS, AACE, DTS)
- How many people, animals or samples were studied?
not applicable; Adults with diabetes
- What was actually found?
Insulin is the cornerstone; glucocorticoids worsen hyperglycaemia.
- How large was the observed effect?
Mortality <1% with treatment
- What do the results mean in everyday life?
Ketoacidosis needs hospital treatment with insulin.
- What are the study's limitations?
Consensus, not trial
- What does it say about Elawady's specific claim?
Directly contradicts C-INS-08; supports danger in C-FAST-03; contradicts C-INS-07, C-INS-10.
- Do the results apply to Germany and Europe?
EASD and JBDS (UK) co-authored; directly applicable.
- What can explicitly not be concluded from this study?
Outcomes of untreated DKA quantitatively.
-
Review on diabetic ketoacidosis
Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1Narrative reviewindependent cross-checkfull text checkedDKA is an emergency that can kill; it is treated with fluids, insulin and salts, and insulin must not be stopped in type 1 diabetes even when not eating.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Epidemiology, pathogenesis, diagnosis and management of DKA
- How was the study done?
Narrative expert review (Nature Reviews Disease Primers)
- How many people, animals or samples were studied?
not applicable; Adults and children with diabetes
- What was actually found?
DKA is diagnosed by high glucose, ketones and acid; it kills <1% when treated in rich countries but up to 26-41% where treatment is lacking; treatment is fluids, insulin and potassium, and insulin must never be stopped in type 1 diabetes even when not eating.
- How large was the observed effect?
not applicable
- What do the results mean in everyday life?
DKA is an emergency.
- What are the study's limitations?
Narrative expert review without systematic methods; one author has research support from insulin makers.
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
International.
- What can explicitly not be concluded from this study?
Quantitative estimates.
-
ADA guideline 2026: blood sugar goals and emergencies
American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006Guideline / position statementindependent cross-checkfull text checked★ key studyMost adults should aim for HbA1c below 7%, avoid low sugar, and measure ketones when at risk.
Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Glycaemic goals, hypoglycaemia and hyperglycaemic crises
- How was the study done?
Clinical practice guideline (ADA Standards of Care 2026, Section 6)
- How many people, animals or samples were studied?
not applicable; People with diabetes
- What was actually found?
Individual targets; do not stop basal insulin when not eating.
- How large was the observed effect?
not applicable
- What do the results mean in everyday life?
Moderate targets and safety rules.
- What are the study's limitations?
US-centred; Partially read
- What does it say about Elawady's specific claim?
Supports C-INS-04, C-INS-11; contradicts C-FAST-01, C-FAST-03, C-DIAB-02.
- Do the results apply to Germany and Europe?
Consistent with EASD guidance.
- What can explicitly not be concluded from this study?
Not applicable.
-
Ketoacidosis with canagliflozin
Erondu N et al.. Diabetes Care 2015 · PMID 26203064 · DOI 10.2337/dc15-1251Othercited by the Tayebat archivefull text checkedKetoacidosis was rare (7 per 10,000 patients), often with insulin deficiency or triggers.
Does the study support the specific claim? Partly · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Incidence of DKA with canagliflozin
- How was the study done?
Pooled safety analysis of randomised trials
- How many people, animals or samples were studied?
17,596; Type 2 diabetes in canagliflozin program
- What was actually found?
DKA 0.07%.
- How large was the observed effect?
0.52-0.76 vs 0.24 per 1,000 PY
- What do the results mean in everyday life?
Rare but real risk.
- What are the study's limitations?
Analysed and written by manufacturer employees; only 12 cases; based on investigator reports (may miss cases).
- What does it say about Elawady's specific claim?
- Do the results apply to Germany and Europe?
Multinational/US/UK data; transferable to EU practice.
- What can explicitly not be concluded from this study?
Precise relative risk; that euglycaemic DKA is common (cases here had high glucose).
No study in this group is marked as key.
Studies with mixed or unclear results (0)
No studies in this group.
Regional context
Germany / EU
German and European emergency practice follows the same consensus (EASD and JBDS are co-authors of I-INS-07).
Egypt
DKA is a common cause of emergency admission of children and young adults with diabetes in Egypt and the region; delayed treatment increases mortality. Advice to avoid hospitals and insulin is particularly dangerous where access to care is already delayed.
What applies in my country?
General scientific assessment
False DKA is deadly without treatment; insulin and fluids save lives, cortisone and dry fasting do not.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.. Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
- Diabetic ketoacidosis.. Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1
- 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006
- Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.. Erondu N et al.. Diabetes Care 2015 · PMID 26203064 · DOI 10.2337/dc15-1251